 |
Investigate all aspects of cell function from misappropriated extracellular matrix to nuclear transcription factors, from biomaterials to cutting edge imaging techniques, and from prognostics, diagnostics, to therapeutics.
|
|
 |
The Clinical Sciences Division seeks to enhance cancer care through innovative research into cancer genetics, novel therapies and stem cell transplants as well as finding better treatment options across all disease areas.
|
|
 |
Focuses on identification of modifiable lifestyle factors, gene-environment interactions and chemopreventive agents for cancer prevention, development of state-of-the-art technologies.
|
|
|
 |
Led by Principal Investigator, Chad A. Mirkin, a National Cancer Institute-funded collaboration between the Lurie Cancer Center and the International Institute for Nanotechnology.
|
|
 |
Brings together physical scientists and cancer biologists to use non-traditional, physical sciences-based approaches to understand and control cancer.
|
|
 |
The Innovation and New Ventures Office inspires and nurtures a culture of innovation, bridging Northwestern research with its practical use for public benefit.
|
|
 |
In 2001, the Lurie Cancer Center was one of eleven cancer centers to receive a $12.5 million five year award from the National Cancer Institute for a SPORE (Specialized Program of Research Excellence) in Prostate Cancer. |
|
|
The research efforts of the Lurie Cancer Center are greatly enhanced by our partnerships |
|
 |
The research efforts of the Lurie Cancer Center are enhanced by multidisciplinary Institutes that support specific research disciplines or disease types.
The Northwestern Brain Tumor Institute (NBTI)
Northwestern Institute for Comparative Effectiveness Research (NICER)
|